Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Nephrology|November 15, 2021
Free vitamin D is independently associated with systolic blood pressure in diabetic patients with impaired kidney functionShufei Zeng, Daniela Bachert, Mira Pavkovic, et al.
Scientific Data|June 16, 2019
Multi omics analysis of fibrotic kidneys in two mouse modelsMira Pavkovic, Lorena Pantano, Cory V Gerlach, et al.
Cell Reports. Medicine|April 6, 2023
Treatment effects of soluble guanylate cyclase modulation on diabetic kidney disease at single-cell resolutionMichael S Balzer, Mira Pavkovic, Julia Frederick, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 17, 2019
A Systems Toxicology Approach for the Prediction of Kidney Toxicity and Its Mechanisms In VitroSusanne Ramm, Petar Todorov, Vidya Chandrasekaran, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 22, 2021
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney diseaseAgnès Bénardeau, Antje Kahnert, Tibor Schomber, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 29, 2016
Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423Mira Pavkovic, Cassianne Robinson-Cohen, Alicia S Chua, et al.
Clinical Chemistry|July 2, 2017
Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic NephropathyMariana Cardenas-Gonzalez, Anand Srivastava, Mira Pavkovic, et al.
International Journal of Molecular Sciences|September 9, 2023
The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 RatsJan R Kraehling, Agnes Benardeau, Tibor Schomber, et al.
Pageof 3